Kestra Investment Management’s SpringWorks Therapeutics SWTX Stock Holding History

Kestra Investment Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-520	Closed	-$24.2K	–	932
2025 Q2	$24.2K	Buy	520 +434	+505%	+$19.3K	﹤0.01%	625
2025 Q1	$3.8K	Buy	+86	New	+$3.96K	﹤0.01%	709

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kestra Investment Management's SWTX Position: Q3 2025 in Review

Kestra Investment Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 520 shares — an estimated $24.2K sold.

Kestra Investment Management first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $24.2K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Kestra Investment Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Kestra Investment Management sold 520 SpringWorks Therapeutics shares in Q3 2025, an estimated $24.2K.
Kestra Investment Management first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Kestra Investment Management's SpringWorks Therapeutics position peaked at $24.2K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Kestra Investment Management's 13F filing for Q3 2025, filed 17 Nov 2025.